Rimegepant is Now Available in the Philippines for Both the Acute Treatment of Migraine and the Preventive Treatment of Episodic Migraine
Rimegepant is the first and onlymedicine approved for both acute and preventive migraine treatment Pfizer Philippines today announces the availability of Rimegepant, a calcitonin gene-related peptide(CGRP) receptorantagonist for both the acute treatment ofmigraine with or without aura...